Nostrum Labs Hits Ch. 11 A Year After Medicaid Settlement

By Rick Archer · October 1, 2024, 11:17 AM EDT

Nostrum Laboratories, a New Jersey drugmaker that paid millions to settle allegations that it underpaid Medicaid drug rebates for its bladder infection drug after it hiked the price more than 400%,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

A New Jersey drugmaker that paid millions to settle allegations that it underpaid Medicaid drug rebates for its bladder infection drug after it hiked the price more than 400%, filed for Chapter 11 protection with nearly $68.3 million in debt.

Case Number

24-bk-19611

Judge

John K. Sherwood

Venue

U.S. Bankruptcy Court for the District of New Jersey

Capital Structure

Total Liabilities:

$68.3 million

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Nostrum Laboratories, Inc.

Case Number

2:24-bk-19611

Court

New Jersey

Nature of Suit

Date Filed

September 30, 2024

Recent Articles By Rick